Cargando…
Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies
Hepatitis C virus (HCV) is a major global health burden as the leading causative agent of chronic liver disease and hepatocellular carcinoma. While the main antigenic target for HCV-neutralizing antibodies is the membrane-associated E1E2 surface glycoprotein, the development of effective vaccines ha...
Autores principales: | Metcalf, Matthew C., Janus, Benjamin M., Yin, Rui, Wang, Ruixue, Guest, Johnathan D., Pozharski, Edwin, Law, Mansun, Mariuzza, Roy A., Toth, Eric A., Pierce, Brian G., Fuerst, Thomas R., Ofek, Gilad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322937/ https://www.ncbi.nlm.nih.gov/pubmed/37407593 http://dx.doi.org/10.1038/s41467-023-39659-z |
Ejemplares similares
-
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate
por: Wang, Ruixue, et al.
Publicado: (2022) -
The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein
por: Tzarum, Netanel, et al.
Publicado: (2018) -
Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
por: Janus, Benjamin M., et al.
Publicado: (2018) -
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells
por: Urbanowicz, Richard A., et al.
Publicado: (2019) -
Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development
por: Toth, Eric A., et al.
Publicado: (2021)